Pricing Log in Create free account
Friday 6 November 2026 Export PBH’s income statement to Excel — free account

Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.

Revenue
+22.7%
EPS
−38.4%
Free cash flow
−38.2%
Total debt
+100.9%

Quarter to September 2026, against a year earlier

44.63 8.65 −16.23%
Market cap
$2.1B
P/E
13.7×
Fwd P/E
11.7×
Dividend yield
—
F-score
5/9
Altman Z
2.48
Beneish M
−2.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Prestige Consumer Healthcare Inc. (PBH) Book value per share

Alert me on Book value per share

Prestige Consumer Healthcare Inc.'s book value per share at the end of fiscal 2026 was 39.0×, up 5.50% from 36.9× in fiscal 2025. At the end of the quarter to 30 September 2026 it was 40.9×. Over the past ten years it has ranged from 12.0× (fiscal 2015) to 39.0× (fiscal 2026) — the current reading is the highest in ten years. Prestige Consumer Healthcare Inc. ranks 4th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2026 39.0× 5.50%
FY2025 36.9× 11.00%
FY2024 33.3× 14.68%
FY2023 29.0× (7.59%)
FY2022 31.4× 16.03%
FY2021 27.1× 17.18%
FY2020 23.1× 9.69%
FY2019 21.0× (5.18%)
FY2018 22.2× 42.96%
FY2017 15.5× 10.04%

Quarterly newest first

Period Book value per share Change
Sep 2026 40.9× 1.39%
Jun 2026 40.4× 3.67%
Mar 2026 39.0× 1.95%
Dec 2025 38.2× 2.64%
43 more quarters

Against its own ten years

Low 12.0× High 39.0×
Ten-year median 25.1×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
PBH Prestige Consumer Healthcare Inc. 40.9×
PRGO Perrigo Company plc compare 17.5×
TRLV Trulieve Cannabis Corp. compare 4.0×
AMLX Amylyx Pharmaceuticals, Inc. compare 2.2×
XERS Xeris Biopharma Holdings, Inc. compare 0.3×
HCM HUTCHMED (China) Limited Sponsored ADR compare 0.0×
RGC Regencell Bioscience Holdings Limited compare 0.0×
ALVO Alvotech compare 0.0×
BCRX BioCryst Pharmaceuticals, Inc. compare −1.6×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on PBH